News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
699,063 Results
Type
Article (39951)
Company Profile (247)
Press Release (658865)
Multimedia
Podcasts (51)
Webinars (12)
Section
Business (204299)
Career Advice (2020)
Deals (35442)
Drug Delivery (95)
Drug Development (81161)
Employer Resources (173)
FDA (16212)
Job Trends (14880)
News (345489)
Policy (32588)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2558)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49467)
ALS (88)
Alzheimer's disease (1382)
Antibody-drug conjugate (ADC) (126)
Approvals (16216)
Artificial intelligence (249)
Autoimmune disease (21)
Automation (16)
Bankruptcy (360)
Best Places to Work (11644)
BIOSECURE Act (19)
Biosimilars (106)
Biotechnology (175)
Bladder cancer (77)
Brain cancer (27)
Breast cancer (278)
Cancer (2251)
Cardiovascular disease (174)
Career advice (1685)
Career pathing (30)
CAR-T (149)
Cell therapy (420)
Cervical cancer (19)
Clinical research (66051)
Collaboration (833)
Compensation (523)
Complete response letters (20)
COVID-19 (2590)
CRISPR (39)
C-suite (237)
Cystic fibrosis (100)
Data (2185)
Decentralized trials (2)
Denatured (18)
Depression (41)
Diabetes (268)
Diagnostics (6368)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (94)
Earnings (86554)
Editorial (35)
Employer branding (22)
Employer resources (147)
Events (112353)
Executive appointments (717)
FDA (17449)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (746)
Gene editing (103)
Generative AI (19)
Gene therapy (301)
GLP-1 (706)
Government (4423)
Grass and pollen (4)
Guidances (54)
Healthcare (18817)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (117)
Indications (29)
Infectious disease (2732)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (96)
Interviews (316)
IPO (16515)
IRA (40)
Job creations (3646)
Job search strategy (1430)
Kidney cancer (10)
Labor market (38)
Layoffs (469)
Leadership (16)
Legal (7931)
Liver cancer (77)
Lung cancer (321)
Lymphoma (153)
Machine learning (7)
Management (58)
Manufacturing (301)
MASH (66)
Medical device (13373)
Medtech (13378)
Mergers & acquisitions (19467)
Metabolic disorders (680)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (91)
Neuropsychiatric disorders (28)
Neuroscience (1913)
NextGen: Class of 2025 (6520)
Non-profit (4483)
Northern California (2650)
Now hiring (39)
Obesity (362)
Opinion (209)
Ovarian cancer (76)
Pain (83)
Pancreatic cancer (83)
Parkinson's disease (148)
Partnered (21)
Patents (231)
Patient recruitment (108)
Peanut (47)
People (57341)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20562)
Phase II (29078)
Phase III (21694)
Pipeline (1174)
Policy (138)
Postmarket research (2568)
Preclinical (8739)
Press Release (64)
Prostate cancer (106)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (381)
Real estate (5915)
Recruiting (66)
Regulatory (22296)
Reports (46)
Research institute (2325)
Resumes & cover letters (350)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (67)
Series A (129)
Series B (84)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2281)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (29)
Startups (3581)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (37)
The Weekly (31)
United States (22890)
Vaccines (685)
Venture capitalists (41)
Weight loss (232)
Women's health (35)
Worklife (15)
Date
Today (217)
Last 7 days (891)
Last 30 days (2681)
Last 365 days (32864)
2025 (10431)
2024 (35237)
2023 (40091)
2022 (51198)
2021 (55732)
2020 (54099)
2019 (46577)
2018 (35052)
2017 (32151)
2016 (31509)
2015 (37568)
2014 (31334)
2013 (26378)
2012 (28602)
2011 (29309)
2010 (27345)
Location
Africa (723)
Alabama (53)
Alaska (7)
Arizona (231)
Arkansas (13)
Asia (37867)
Australia (6199)
California (6058)
Canada (2002)
China (518)
Colorado (265)
Connecticut (272)
Delaware (146)
Europe (81307)
Florida (900)
Georgia (203)
Idaho (57)
Illinois (529)
India (25)
Indiana (306)
Iowa (11)
Japan (158)
Kansas (104)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (884)
Massachusetts (4527)
Michigan (216)
Minnesota (388)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1708)
New Mexico (28)
New York (1726)
North Carolina (959)
North Dakota (8)
Northern California (2650)
Ohio (202)
Oklahoma (14)
Oregon (34)
Pennsylvania (1366)
Puerto Rico (12)
Rhode Island (33)
South America (1099)
South Carolina (22)
South Dakota (1)
Southern California (2281)
Tennessee (101)
Texas (897)
Utah (180)
Virginia (143)
Washington D.C. (61)
Washington State (549)
West Virginia (3)
Wisconsin (53)
699,063 Results for "genentech inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Genentech Offers up to $765M in Biobucks to Repertoire for I&I Drug Discovery
Roche’s Genentech is betting on the Flagship Pioneering–founded company’s discovery platform called DECODE to find new targets for an undisclosed autoimmune disorder.
April 23, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
FDA Approves Genentech’s TNKase® in Acute Ischemic Stroke in Adults
March 3, 2025
·
9 min read
Layoffs
Genentech to Lay Off 93 in San Francisco
Genentech’s latest layoffs are the second round of workforce reductions this year, following the company’s announcement in April that it was letting go around 3% of employees.
August 28, 2024
·
1 min read
·
Angela Gabriel
Press Releases
FDA Accepts Supplemental Biologics License Application for Genentech’s Gazyva for the Treatment of Lupus Nephritis
March 5, 2025
·
19 min read
Business
Genentech Shutters Cancer Immunology Group Amid Wider R&D Reprioritization
The unit’s closure comes as Genentech’s parent Roche rethinks its cancer business, an effort that has included the discontinuation of three early-stage candidates and a T-cell partnership with Adaptimmune.
August 19, 2024
·
2 min read
·
Tristan Manalac
Press Releases
FDA Approves Genentech’s Evrysdi Tablet as First and Only Tablet for Spinal Muscular Atrophy (SMA)
February 13, 2025
·
9 min read
Press Releases
Repertoire® Immune Medicines Enters into Collaboration and License Agreement with Genentech for the Development of T cell-Targeted Therapies for an Autoimmune Disease
April 24, 2025
·
3 min read
Press Releases
Genentech and Roche Present Novel Therapeutic and Diagnostic Advancements in Alzheimer’s at AD/PD 2025
April 3, 2025
·
6 min read
Press Releases
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
February 4, 2025
·
11 min read
Press Releases
Genentech Provides Update on Phase III Ocrevus High Dose Study in People With Relapsing Multiple Sclerosis
April 3, 2025
·
15 min read
1 of 69,907
Next
